Matches in Nanopublications for { ?s ?p "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492768.RAd3r4gUnyEL0rzlrwmcpgxfs2eJ4rcfU9OBFcGHNTS2s130_provenance.
- NP546560.RAOBbkqBrpmN0BhmKWDaABAVD-_riXK-QDZpuD9C-j1JY130_assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546560.RAOBbkqBrpmN0BhmKWDaABAVD-_riXK-QDZpuD9C-j1JY130_provenance.
- assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_assertion description "[Mice immunized with murine mammary carcinoma cells genetically engineered to secrete interleukin-2 (IL-2) are rendered resistant to subsequent challenge with unmodified tumor cells, and in the case of mice bearing established tumors, the rate of development of pulmonary metastases is reduced.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1378780.RAsQPuwG67xHU0mf5JMu47XMXheVMRNA3Hs_ftN2XpnEg130_provenance.